ArticlePloS one2016

Angiotensin Converting-Enzyme Inhibitors, Angiotensin Receptor Blockers, and Calcium Channel Blockers Are Associated with Prolonged Vascular Access Patency in Uremic Patients Undergoing Hemodialysis.

Fu-An Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.